Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TNKS2 | Q9H2K2 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.37 |
| ▸ | HTR2A | P28223 | 3/20 | 0.36 |
| ▸ | PTGDR2 | Q9Y5Y4 | 1/20 | 0.35 |
| ▸ | NUDT1 | P36639 | 1/20 | 0.35 |
| ▸ | BACE1 | P56817 | 1/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
| ▸ | FASN | P49327 | 1/20 | 0.34 |
| ▸ | FKBP1A | P62942 | 3/20 | 0.34 |
| ▸ | PDE4D | Q08499 | 3/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6568830 | 0.92 | ALDH1A1 (0.38) | ALDH1A1HTR2APTGDR2NUDT1BACE1 | |
| SCHEMBL6567794 | 0.84 | TNKS2 (0.42) | TNKS2ALDH1A1HTR2APTGDR2NUDT1 | |
| SCHEMBL7794938 | 0.84 | THRA (0.47) | ALDH1A1PTGDR2 | |
| SCHEMBL7941368 | 0.83 | ALDH1A1 (0.47) | ALDH1A1PTGDR2 | |
| SCHEMBL2913942 | 0.83 | TNKS2 (0.40) | TNKS2NUDT1BACE1KDM4E | |
| SCHEMBL6567002 | 0.82 | TNKS2 (0.40) | TNKS2ALDH1A1HTR2APTGDR2NUDT1 | |
| SCHEMBL7796573 | 0.81 | THRB (0.46) | ALDH1A1PTGDR2 | |
| SCHEMBL8433312 | 0.80 | L3MBTL1 (0.44) | ALDH1A1PTGDR2 | |
| SCHEMBL6568807 | 0.76 | ALDH1A1 (0.38) | ALDH1A1HTR2APTGDR2NUDT1BACE1 | |
| SCHEMBL6567763 | 0.75 | TNKS2 (0.47) | TNKS2HTR2APTGDR2NUDT1BACE1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1484334-A2 | Process for producing phosphite | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2004-12-08 | — | — | EP | disclosed |
| US-20040225145-A1 | Process for producing phosphite | SUMITOMO CHEMICAL COMPANY, LIMITED | 2004-11-11 | — | — | US | disclosed |
| US-6242514-B1 | CYCLIC PHOSPHATE OR PHOSPHONATE; HEAT AND OXIDATION STABILIZER ESPECIALLY FOR OLEFIN POLYMERS AND ENGINEERING THERMOPLASTICS | SUMITOMO CHEMICAL COMPANY, LTD. (JP) | 2001-06-05 | — | — | US | disclosed |
| US-5914361-A | IMPART HEAT STABILITY TO ORGANIC MATERIALS, INCLUDING POLYOLEFINS | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1999-06-22 | — | — | US | disclosed |
| US-5889095-A | OXYGEN AND HEAT RESISTANCE | SUMITOMO CHEMICAL COMPANY, LTD. (JP) | 1999-03-30 | — | — | US | disclosed |
| EP-0823435-A2 | Phosphites, process for producing the same and their use | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1998-02-11 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040225145-A1 | Process for producing phosphite | PHOSPHO1, PLCG1, PLCG2 | TNKS2 3019/4885ALDH1A1 4488/4885HTR2A 4188/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.